Cargando…
Predicting and designing therapeutics against the Nipah virus
Despite Nipah virus outbreaks having high mortality rates (>70% in Southeast Asia), there are no licensed drugs against it. In this study, we have considered all 9 Nipah proteins as potential therapeutic targets and computationally identified 4 putative peptide inhibitors (against G, F and M prot...
Autores principales: | Sen, Neeladri, Kanitkar, Tejashree Rajaram, Roy, Ankit Animesh, Soni, Neelesh, Amritkar, Kaustubh, Supekar, Shreyas, Nair, Sanjana, Singh, Gulzar, Madhusudhan, M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907750/ https://www.ncbi.nlm.nih.gov/pubmed/31830030 http://dx.doi.org/10.1371/journal.pntd.0007419 |
Ejemplares similares
-
Packpred: Predicting the Functional Effect of Missense Mutations
por: Tan, Kuan Pern, et al.
Publicado: (2021) -
Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic
por: Gazal, Sabahat, et al.
Publicado: (2022) -
NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus
por: Gupta, Amit Kumar, et al.
Publicado: (2020) -
Protein Interaction Z Score Assessment (PIZSA): an empirical scoring scheme for evaluation of protein–protein interactions
por: Roy, Ankit A, et al.
Publicado: (2019) -
Evolutionary flexibility and rigidity in the bacterial methylerythritol phosphate (MEP) pathway
por: Marshall, Bailey, et al.
Publicado: (2023)